Sorrento Therapeutics Ink. (Seite 70)
eröffnet am 24.06.19 16:11:40 von
neuester Beitrag 24.04.24 17:05:59 von
neuester Beitrag 24.04.24 17:05:59 von
Beiträge: 1.316
ID: 1.306.128
ID: 1.306.128
Aufrufe heute: 48
Gesamt: 93.140
Gesamt: 93.140
Aktive User: 0
ISIN: US83587F2020 · WKN: A1W8DY · Symbol: SRNE
0,0200
USD
0,00 %
0,0000 USD
Letzter Kurs 15:53:03 Nasdaq OTC
Neuigkeiten
12.09.23 · globenewswire |
07.09.23 · globenewswire |
27.07.23 · globenewswire |
05.07.23 · globenewswire |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,9000 | +59,66 | |
2,2999 | +25,68 | |
1,9200 | +23,87 | |
0,5298 | +17,47 | |
6,9300 | +17,46 |
Wertpapier | Kurs | Perf. % |
---|---|---|
3,6600 | -14,29 | |
0,5050 | -15,83 | |
3,0900 | -18,63 | |
0,5834 | -21,16 | |
1,9500 | -25,14 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 67.633.663 von Haschki am 29.03.21 08:06:12Danke für das Video! Mein Vertrauen in Sorrento und deren Pipeline ist ungebrochen, auch wenn ich mir eine schnellere Zulassung gewünscht hätte. Werde trotzdem nachlegen, die Kurse laden dazu ein.
Antwort auf Beitrag Nr.: 67.631.908 von Unicorn71 am 28.03.21 20:14:00
37 Year Pro Stock Trader Backs Up His BULLISH Outlook On SRNE
Vielleicht liegt es an der Manaus Variante, die ja wohl hochgradig aggressiv ist und gerade erst richtig zu grassieren beginnt. Womöglich will man die Wirksamkeit gegen diese Variante noch mal in Augenschein nehmen, bevor man an die Öffentlichkeit tritt...
Zeit wäre es allerdings! Dachte wir wären längst weiter...
Zeit wäre es allerdings! Dachte wir wären längst weiter...
Was mich irritiert ist diese extreme Ruhe was die Ergebnisse ok Brasilien angeht
Antwort auf Beitrag Nr.: 67.606.605 von Charly_2 am 25.03.21 21:35:39Bisher hat weltweit noch keine Firma dieselbe Therapie in Evaluation
Schönes Kursniveau um loszulegen :-)
$8.62
https://investors.sorrentotherapeutics.com/news-releases/new…
$8.62
https://investors.sorrentotherapeutics.com/news-releases/new…
Extreme Verschlechterung für die Shorts am Horizont, sie dürfen ab dem 1.4. nicht mehr viermal so viel Aktien kaufen, wie sie funds haben; das war eine Ausnahmeregelung wegen Covid (das verstehe, wer will, ich nicht), sie konnten ähnlich wie Banken agieren, die viermal soviel Geld verleihen können, wie sie besitzen. Sehen wir dann reale Kurse?
DJrob
@jaggeddeath 24. März Twitter Because of covid, they were allowed to buy and short more shares, than they had funds for. Similar to banks loaning out four times more money, than they had on hand. It started 04/01/20. That ends 03/31/21
DJrob
@jaggeddeath 24. März Twitter Because of covid, they were allowed to buy and short more shares, than they had funds for. Similar to banks loaning out four times more money, than they had on hand. It started 04/01/20. That ends 03/31/21
Zumindest sollten sie langsam mal liefern. CEO sagt ja, EUA sein nur noch Stunden entfernt... Nun ja, er sagte auch Shorts sollen nicht ihre Familie ruinieren... Langsam muß er sich mal an seinen Worten messen lassen, die Geduld schwindet...
Allerdings war es vergangenes Jahr bei Novavax im April ähnlich...Jeder wartete und ich war schon mehrmals kurz davor zu schmeißen und dann WUSCH...Der Rest ist Geschichte...
Vielleicht läuft es hier ja ähnlich!
Allerdings war es vergangenes Jahr bei Novavax im April ähnlich...Jeder wartete und ich war schon mehrmals kurz davor zu schmeißen und dann WUSCH...Der Rest ist Geschichte...
Vielleicht läuft es hier ja ähnlich!
Antwort auf Beitrag Nr.: 67.505.732 von Charly_2 am 18.03.21 08:46:24Na ja, scheint wohl eh zu optimistisch :-)
Der CEO hält ne Menge Holz, ua. 1.8 Mio Aktien zu $6.40 gekauft
https://fintel.io/n/us/srne/ji-henry
Der CEO hält ne Menge Holz, ua. 1.8 Mio Aktien zu $6.40 gekauft
https://fintel.io/n/us/srne/ji-henry
200 Mrd. Market Cap als Ziel 🤑
Aktuell Market Cap: 2.8 Mrd.
Das wäre Faktor 71.4*$10=$714/Aktie💰💰
Präsentation Sorrento, gestern -
Yahoo Board von Wise
From today's conference, GhostPositions @ Stocktwits has a well captured summary...
"CoviStix in comparison to Abbott test is 5 times more potent in detection" ... "We have EUA submitted in USA, Mexico, and many of the European Countries, and are expecting the approvals to come through any moment." - Dr. Ji
"With regard to nasal drop antibody modality in our discussion with the FDA we know we are THE FIRST ONE to develop nose drop antibodies" ... "We are the only FDA application for nasal drop antibodies" ... "This explains the delay in application and consideration for trials as new modality requires toxicity data that we luckily acquired in only 2 months"... "We have antibodies against UK, South African, Washington, and Brazil variants." "We are putting 2 antibodies together as a cocktail that will be effective against all known variants." - Dr. Ji
"One thing we have not discussed publicly, is antiviral, that would overcome any potential variants." ..."this could apply to the flu, HIV, and all Covid variants." ... "This would be the HOLY GRAIL of potential treatments..." - Dr. Ji
"We have a sales team in place for all potential products. As soon as we receive approval we will be able to go straight to market. We expect several EUA approvals that will bring billions and billions of dollars revenue over the next 2-3 years." ... "We believe we are building a company with the opportunity for multi-multi-billion dollar revenue." ... "My goal is in the next 5 years or so to be a 200 billion market cap biopharm." "We have all of the tools, all of the manufacturing, and all of the team to bring this to reality."- Dr. Ji
"Our goal is treating our stakeholders very nicely into the future. Thank you for your confidence in our company. We love your support." - Dr. Ji
Aktuell Market Cap: 2.8 Mrd.
Das wäre Faktor 71.4*$10=$714/Aktie💰💰
Präsentation Sorrento, gestern -
Yahoo Board von Wise
From today's conference, GhostPositions @ Stocktwits has a well captured summary...
"CoviStix in comparison to Abbott test is 5 times more potent in detection" ... "We have EUA submitted in USA, Mexico, and many of the European Countries, and are expecting the approvals to come through any moment." - Dr. Ji
"With regard to nasal drop antibody modality in our discussion with the FDA we know we are THE FIRST ONE to develop nose drop antibodies" ... "We are the only FDA application for nasal drop antibodies" ... "This explains the delay in application and consideration for trials as new modality requires toxicity data that we luckily acquired in only 2 months"... "We have antibodies against UK, South African, Washington, and Brazil variants." "We are putting 2 antibodies together as a cocktail that will be effective against all known variants." - Dr. Ji
"One thing we have not discussed publicly, is antiviral, that would overcome any potential variants." ..."this could apply to the flu, HIV, and all Covid variants." ... "This would be the HOLY GRAIL of potential treatments..." - Dr. Ji
"We have a sales team in place for all potential products. As soon as we receive approval we will be able to go straight to market. We expect several EUA approvals that will bring billions and billions of dollars revenue over the next 2-3 years." ... "We believe we are building a company with the opportunity for multi-multi-billion dollar revenue." ... "My goal is in the next 5 years or so to be a 200 billion market cap biopharm." "We have all of the tools, all of the manufacturing, and all of the team to bring this to reality."- Dr. Ji
"Our goal is treating our stakeholders very nicely into the future. Thank you for your confidence in our company. We love your support." - Dr. Ji
12.09.23 · globenewswire · Sorrento Therapeutics |
07.09.23 · globenewswire · Sorrento Therapeutics |
27.07.23 · globenewswire · Sorrento Therapeutics |
05.07.23 · globenewswire · Sorrento Therapeutics |
26.06.23 · globenewswire · Sorrento Therapeutics |
13.06.23 · globenewswire · Sorrento Therapeutics |
05.06.23 · globenewswire · Sorrento Therapeutics |